Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA review challenges Amgen on a questionable T-Vec study
FDA review challenges Amgen on a questionable T-Vec study
FDA review challenges Amgen on a questionable T-Vec study
Submitted by
admin
on April 27, 2015 - 9:46am
Source:
Fierce Biotech
News Tags:
FDA
Amgen
T-Vec
Talimogene Laherparepvec
cancer
cancer vaccines
Headline:
FDA review challenges Amgen on a questionable T-Vec study
Do Not Allow Advertisers to Use My Personal information
